Premier Alternatives

Araceli Biosciences

Tigard, OR · Founded 2020 · Privately Held (backing)

Developer of advanced imaging technologies intended to enhance the drug discovery process for researchers. Araceli Biosciences is based in Tigard, OR and was founded in 2020. It was valued at $27 million at its seed round in Nov 2025, the last priced event on record. It has raised $14.5 million across 2 recorded rounds; the latest was a $12.2 million early-stage round in Dec 2024.

PMV mark · valuation
$27.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$14.5M
Last round
Early Stage VC
Dec 2024

Araceli Biosciences key facts

as of Oct 2026
  • Developer of advanced imaging technologies intended to enhance the drug discovery process for researchers.
  • Araceli Biosciences is valued at approximately $27.0M as of Oct 2026, set at its seed round, Nov 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $14.5M across 2 recorded rounds; the latest was Early Stage VC ($12.2M) in Dec 2024.
  • Notable investors include Fluke Venture Partners, William Cortelyou.
  • Araceli Biosciences has filed 3 Form Ds with the SEC since 2023, most recently Dec 2025 ($12.2M sold to 28 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$27.0M

Valued at $27.0M at its seed round, Nov 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Araceli Biosciences with a free account
  • ·Watch Araceli Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Araceli Biosciences funding rounds

2 rounds
Dec 2024Early Stage VC$12.2MSEC filing▮
Apr 2023Seed Round$2.2MSEC filing▮
Full funding history →

Who backs Araceli Biosciences

2
Fluke Venture PartnersWilliam Cortelyou

Araceli Biosciences valuation

Araceli Biosciences was valued at $27 million at its seed round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Araceli Biosciences raised?

Araceli Biosciences has raised $14.5 million across 2 recorded rounds since 2023. The largest was a $2.2 million seed round in Apr 2023; the most recent was a $12.2 million early-stage round in Dec 2024.

Araceli Biosciences has filed 3 Form Ds with the SEC since 2023, most recently in Dec 2025 ($12.2 million sold to 28 investors).

Araceli Biosciences investors

2 investors are on record for Araceli Biosciences, including Fluke Venture Partners and William Cortelyou. The early-stage round in Dec 2024 drew 28 investors.

About Araceli Biosciences

Developer of advanced imaging technologies intended to enhance the drug discovery process for researchers. The company's technologies offer features such as predictive AI-based image acquisition and analysis, rapid scanning capabilities that reduce the time for screening compounds, and hardware, enabling pharmaceutical and biotech companies to streamline their research efforts while providing an efficient path to therapeutic development and improved patient outcomes.

Sector
Healthcare
HQ
Tigard, OR, United States
Founded
2020
Employees
45
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.